Client login Menu Pharmacodynamic Biomarker Testing Home / Diagnostic Services / Pharmacodynamic Biomarker Testing Our Services Our Services Genomic Services Clinical Trial Assays Clinical Trial Assays Pharmacodynamic Biomarker Testing Clinical Trial Assay Companion Diagnostics Global Clinical Trial Testing Almac PD Biomarker Testing Service Almac Diagnostic Services can help Biopharma clients validate reliable PD assays that can help provide invaluable guidance within their drug development programmes. Almac can develop and perform PD testing on multiple technology platforms across multiple sample types for qPCR and Next Generation Sequencing (NGS) from our global CLIA and CAP-accredited labs. Clients may wish to provide previous existing data from matched pre- and post-treatment samples and our Data Sciences team can provide solutions for selection of an appropriate PD biomarker, alternatively, clients may already have a pre-defined PD biomarker they would like Almac to test for them. Almac Diagnostic Services has extensive experience in PD Biomarker Testing. As part of our overall Clinical Trial Solutions we can deliver for clients either: An independent PD Biomarker measurement A PD Biomarker measurement integrated with a predictive clinical trial assay (CTA) If a client chooses Almac for combined delivery of both the predictive and PD biomarker within their clinical trial programme Almac can deliver significant efficiencies in terms of time and cost savings. Specific efficiencies can be gained through centralised sample management, pathology review & nucleic acid extraction. Benefits Streamlined Process & Combined Efficiencies Utilising Almac as a centralised provider, rather than outsourcing PD biomarker work and CTA development work to multiple CRO vendors, creates a much more streamlined process. This also results in logistics efficiencies and reduced risk for client’s drug development programmes. Cost & Time Savings This can directly translate into savings for clients with a ‘same sample, same lab’ approach of combined PD biomarker and CTA testing saving time and reducing cost with one provider. Better Informed Decision Making Combining drug development data with biomarker efficacy data from Almac focused PD biomarker measurements provides critical information to help inform key drug development milestone decisions much earlier on in the process. Almac’s unique gene expression report claraTalso allows cancer researchers to discover novel insights within pharmacodynamic (PD) biomarker discovery. By allowing multiple biologies to be evaluated in parallel, the claraT Total mRNA Report supports the identification of pre and post expression changes within novel pathways and biologies that may play a role in response to therapeutic targets. Example of Almac PD Biomarker Process integrated with a Clinical Trial Assay PD Biomarker and predictive CTA combined activity in the same Almac laboratory providing streamlined efficiencies for clients. Pharmacokinetic Analysis For clients also interested in Pharmacokinetic (PK) analysis, Almac Group can provide this service through our Almac Sciences business unit. Almac has the ability to provide both bioanalysis and PK data on an interim basis facilitating our clients to make decisions on a continuous basis. This is particularly useful at the ‘Proof of Concept’ phase or ‘Dose Escalation’ studies where the pharmacokinetic data is often crucial to making important safety decisions regarding dosing. Almac Sciences has 4 study directors for bioanalysis & PK studies, each with more than 20 years’ experience in the field. Find out more – To view a full list of Bioanalysis / PK assays. Contact Us Interested in PD Biomarker testing in conjunction with predictive biomarker testing as part of your Clinical Trial? Get in touch with Almac Diagnostic Services for a quote. First Name* Last Name* Job Title* Company name* Business email* Confirm you have read and accepted the Almac Privacy Policy* *By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to info@almacgroup.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list. Stay up-to-date with Almac Diagnostic Services Join our mailing list Services Our Services Our Services Genomic Services Genomic Services Clinical Trial Assays Clinical Trial Assays Pharmacodynamic Biomarker Testing Clinical Trial Assay Companion Diagnostics Companion Diagnostics CDx Development & Validation CDx Manufacturing CDx Commercialisation Global Clinical Trial Testing Global Clinical Trial Testing Clinical Testing Sample Management Service Sample Kit Design & Manufacturing Supporting Services Supporting Services Data Sciences Bioinformatics Biostatistics Software claraT Report Whitepaper Fact Sheet Brochure Complimentary Webinar RNA Blog Whole Exome Sequencing (WES) Service Genomic Variant RUO Report Regulatory Support Project Management Clinical Support Clinical Support Pathology Why Almac The Almac Difference Global BioPharma Partners Global Laboratories Global Laboratories Platforms & Technologies Platforms & Technologies DNA-Sequencing Solutions RNA-Sequencing Solutions Liquid Biopsy Solutions Quality Management System Lab Virtual Tour Resources, News & Events News Events Publications Articles Posters Videos Webinars Almac Voice Almac R&D Assays Almac R&D Assays Overview DDIR Angio EMT Prostate DX ColDx About Us Meet the Team Our History The Almac Group Government R&D Support Careers Contact Us Our BD Team Laboratory Locations Sign up for our newsletter Contact Us Get in touch Diagnostic Services contact number +44 (0) 28 3833 2200 Diagnostic Services contact number +1 (215) 660 8500 Diagnostic Services contact number +65 6309 0720 Diagnostic Services Email diagnostics@almacgroup.com Diagnostic Services Careers Enquiries careers@almacgroup.com Social links linkedin twitter youtube vimeo ©2020 Almac Group Company information Terms & Conditions Privacy & Cookie Policy By continuing to browse the site, you are agreeing to our use of cookies Agree